High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer-Reference-Cited by-同舟云学术

High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer

Published:2010-08-31 Issue:3 Volume:71 Page:281-288
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Minner Sarah,Wittmer Corinna,Graefen Markus,Salomon Georg,Steuber Thomas,Haese Alexander,Huland Hartwig,Bokemeyer Carsten,Yekebas Emre,Dierlamm Judith,Balabanov Stefan,Kilic Ergin,Wilczak Waldemar,Simon Ronald,Sauter Guido,Schlomm Thorsten

Publisher

Wiley

Subject

Urology,Oncology

Reference45 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Validating cancer drug targets;Benson;Nature,2006

3. Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: A trial of the National Cancer Institute of Canada-Clinical Trials Group;Canil;J Clin Oncol,2005

4. An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer;Pezaro;Am J Clin Oncol,2009

5. A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer;Stadler;Clin Cancer Res,2004

Cited by 241 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial;European Urology;2024-09

2. Quantitative ⁶⁸Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following ¹⁷⁷Lu-PSMA-617 (VISION Trial);Radiology;2024-08-01

3. Predictors of Metastasis in 68GA-Prostate Specific Membrane Antigen Pet-CT in the Primary Staging of Prostate Cancer;Journal of Clinical Medicine;2024-05-08

4. An Analysis of the Diagnostic Performance of Tc-99m PSMA SSPECT/CT in Biochemically Recurrent Prostate Cancer Compared with Ga-68 PSMA PET/CT: A Single-center, Prospective Study;Indian Journal of Nuclear Medicine;2024-05

5. PSMAx-Guided PROTAC Degraders for Tumor-Specific Protein Degradation in Prostate Cancer;2024-04-26